ELMIRON® should be taken by mouth, 1 capsule 3 times a day, with water, at least 1 hour before meals or 2 hours after meals. Each capsule contains 100 mg of ELMIRON®.
Clinical response may require 3 to 6 months of continuous therapy. Patients should be reassessed after 3 months. If improvement has not occurred and if limiting adverse events are not present, ELMIRON® may be continued for another 3 months. Discussing this with patients right from the start of therapy is important. The clinical value and risks of continued treatment in patients whose pain has not improved by 6 months is not known.
Please see full Prescribing Information for ELMIRON®